Living Cell will grant Otsuka rights to develop and commercialize DiabeCell in Japan and other Asian countries, excluding China

Living Cell Technologies Ltd.

Australia / Small-Cap Biopharma (<$1 billion)

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Otsuka Pharmaceutical Co. Ltd.

Japan / Private Biopharma

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Letter of Intent

Sample

01/01/2009

announced